Literature DB >> 17063733

Use of an in vitro assay for determination of biofilm-forming capacity of bacteria in chronic rhinosinusitis.

Zohra Bendouah1, Jean Barbeau, Walid Abou Hamad, Martin Desrosiers.   

Abstract

BACKGROUND: Bacterial biofilms are increasingly implicated in the pathogenesis of chronic disease and have been established in several chronic ear, nose, and throat conditions, including chronic sinusitis (CRS). However, this relies on specialized imaging methods not widely available. We wished to assess the capacity of an easily performed, inexpensive in vitro test to assess biofilm production by bacteria recovered from individuals with CRS with or without nasal polyposis.
METHODS: Bacterial isolates were recovered from patients consulting an academic tertiary rhinology practice. Biofilm formation was determined with an in vitro staining method using crystal violet. Ten isolates of Pseudomonas aeruginosa, Staphylococcus aureus, and 11 of coagulase-negative staphylococcus from patients with CRS having previously undergone endoscopic sinus surgery for >1 year were assessed. Samples were cultured 24 hours at 37 degrees C on 96-well plates in tryptic soy broth 0.5% glucose medium. After staining with crystal violet, optical density at 570 nm was measured to quantify biofilm production. Biofilm-forming capacity was compared with positive and negative controls for each species obtained from commercial sources.
RESULTS: Positive controls all grew biofilms, with a tendency of lesser biofilm formation at higher dilutions. Twenty-two of 31 clinical samples produced a biofilm greater or equal to the positive control. Biofilm was recovered consistently for all three species studied.
CONCLUSION: This in vitro assessment method is capable of detecting biofilm-forming capacity in bacteria recovered from individuals with CRS. This simple assay may be a useful complement to existing techniques for clinical research.

Entities:  

Mesh:

Year:  2006        PMID: 17063733     DOI: 10.2500/ajr.2006.20.2930

Source DB:  PubMed          Journal:  Am J Rhinol        ISSN: 1050-6586


  6 in total

1.  Determination of the biofilm formation capacity of bacterial pathogens associated with otorhinolaryngologic diseases in the Malaysian population.

Authors:  Yalda Khosravi; Lina Chooi Ling; Mun Fai Loke; Sivalingam Shailendra; Narayanan Prepageran; Jamuna Vadivelu
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-07-24       Impact factor: 2.503

2.  Bacterial biofilm in upper respiratory tract infections.

Authors:  David P Morris
Journal:  Curr Infect Dis Rep       Date:  2007-05       Impact factor: 3.725

3.  Bacterial biofilms are associated with inflammatory cells infiltration and the innate immunity in chronic rhinosinusitis with or without nasal polyps.

Authors:  Xin Wang; Jing Du; Chunyuan Zhao
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

4.  l-Methionine anti-biofilm activity against Pseudomonas aeruginosa is enhanced by the cystic fibrosis transmembrane conductance regulator potentiator, ivacaftor.

Authors:  Do-Yeon Cho; Dong-Jin Lim; Calvin Mackey; Christopher G Weeks; Jaime A Peña Garcia; Daniel Skinner; Jessica W Grayson; Harrison S Hill; David K Alexander; Shaoyan Zhang; Bradford A Woodworth
Journal:  Int Forum Allergy Rhinol       Date:  2018-02-07       Impact factor: 3.858

Review 5.  The role of bacterial biofilms and the pathophysiology of chronic rhinosinusitis.

Authors:  Shaun J Kilty; Martin Y Desrosiers
Journal:  Curr Allergy Asthma Rep       Date:  2008-05       Impact factor: 4.919

6.  Biofilm-Forming Methicillin-Resistant Staphylococcus aureus Survive in Kupffer Cells and Exhibit High Virulence in Mice.

Authors:  Takuto Oyama; Motoyasu Miyazaki; Michinobu Yoshimura; Tohru Takata; Hiroyuki Ohjimi; Shiro Jimi
Journal:  Toxins (Basel)       Date:  2016-06-30       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.